R&D Systems™ Recombinant Human ICAM-2/CD102 Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Description

The Recombinant Human ICAM-2/CD102 Fc Chimera Protein is derived from NS0. The Recombinant Human ICAM-2/CD102 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS containing Calcium and Magnesium with Sorbitol.
• Molecular Weight (g/mol): 50 kDa (monomer)
• Source: Mouse myeloma cell line,NS0-derived human ICAM-2/CD102 protein, (N-terminus) Human ICAM-2 (Lys25-Gln223) Accession &Num; CAA33630 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Recombinant: Recombinant

• Gene ID (Entrez): 3384
• Name: ICAM-2/CD102 Fc Chimera
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.